CA Patent

CA2047029A1 — Microbial transformation process for antihypertensive products

Assigned to Merck and Co Inc · Expires 1992-01-20 · 34y expired

What this patent protects

TITLE OF THE INVENTION MICROBIAL TRANSFORMATION PROCESS FOR ANTIHYPERTENSIVE PRODUCTS ABSTRACT OF THE DISCLOSURE Fermentation of the microorganism Streptomyces sp. MA6751 (ATCC No. 55043) in the presence of the Angiotensin II (A II) receptor antagonist (II) 12/…

USPTO Abstract

TITLE OF THE INVENTION MICROBIAL TRANSFORMATION PROCESS FOR ANTIHYPERTENSIVE PRODUCTS ABSTRACT OF THE DISCLOSURE Fermentation of the microorganism Streptomyces sp. MA6751 (ATCC No. 55043) in the presence of the Angiotensin II (A II) receptor antagonist (II) 12/CSQ2 - i - 18157 yields an N2-tetrazole .beta.-glucuronide analog which is also an A II antagonist useful in the treatment of hypertension and congestive heart failure and other indications known to respond to A II antagonists.

Drugs covered by this patent

Patent Metadata

Patent number
CA2047029A1
Jurisdiction
CA
Classification
—
Expires
1992-01-20
Drug substance claim
No
Drug product claim
No
Assignee
Merck and Co Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.